Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
A prescriber my write a prescription in Units or in mLs
Safety profile: Are there any low-frequency adverse events that emerge with larger populations
The primary outcome was the overall point prevalence of smoking abstinence when comparing the effects of GLP-1 receptor agonists (RA) with placebo, using two-tailed tests and a significance threshold of p 60%), and imprecision of the pooled estimate
Intervention Seventy eligible participants were randomly assigned (1:1) to either semaglutide 2.4 mg weekly (Novo Nordisk) ( n = 35) or placebo (saline solution) ( n = 35), using self-administered once-weekly subcutaneous injections with identical-appearing pens
Blue Cross Blue Shield of Michigan will pull back on coverage for GLP-1 drugs amid rising costs for these products
